BMY Bristol-Myers Squibb Company | US1101221083
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 46.395.652.990 | 47.457.986.950 | 2.24% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 6,20 | 6,34 | 2.31% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 25 | 27 | 7.41% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |